산소 요법 시장 규모, 점유율, 동향 및 예측 : 제품별, 용도별, 최종 용도별, 지역별(2026-2034년)

The global oxygen therapy market size was valued at USD 21.4 Billion in 2025. The market is projected to reach USD 35.4 Billion by 2034, exhibiting a CAGR of 5.58% from 2026-2034. North America currently dominates the market, holding a market share of over 37.9% in 2025. The oxygen therapy market worldwide is expanding rapidly due to a higher incidence of respiratory conditions and a growing preference for home-based medical care. Notable trends shaping the market include advances in portable and wearable oxygen delivery systems, the incorporation of smart technologies, and greater emphasis on tailoring therapy to individual patient needs.

The oxygen therapy market is primarily driven by the increasing incidence of diseases such as chronic obstructive pulmonary disease (COPD) and asthma, which require long-term oxygen therapy. For instance, Emerson developed the ASCO(TM) Series 588 Stationary Oxygen Concentrator Manifold as a complete package for respiratory therapy layouts and to help expedite time to market. In addition, the enhanced portable oxygen devices give mobile support, which allows easy installation for in-home healthcare needs, aiding the market growth. Moreover, the percentage of the aging population group triggers respiratory illnesses more frequently, which is significantly expanding the oxygen therapy market share. Besides this, the increased understanding of the benefits associated with oxygen therapy is boosting the use of oxygen across the globe, providing an impetus to the market. Apart from this, the continuous innovation in oxygen concentrators enhances the impact of treatment, thereby catalyzing the market growth.

The United States holds a share of 88.70% in the oxygen therapy market. The demand in the region is expanding, due to the increasing incidence of diseases of the respiratory system, especially COPD. Moreover, the increase in health care costs and insurance is driving the demand for oxygen therapies, supporting the market growth. Concurrently, continuous developments in home healthcare technology make it possible for patients to receive oxygen therapy at home, which is fueling the market demand. Also, higher public awareness of how respiratory health is valuable promotes early treatment, thus strengthening the market share. Apart from this, the government initiatives for chronic disease management increase oxygen prescription, as air pollution increases the burden of respiratory diseases, thereby propelling the market forward.

OXYGEN THERAPY MARKET TRENDS:

Home healthcare trends

Most patients especially the elderly and those with chronic diseases prefer to be treated at home instead of in hospitals or nursing homes. At-home care is often relatively cheaper as the devices are portable, and easy to manage, allowing the patient to maintain their mobility and freedom. The IMARC Group reports that the global home healthcare market reached USD 392.2 Billion in 2023. Most chronic respiratory conditions such as COPD and pulmonary fibrosis require oxygen therapy for the long term. Additionally, home healthcare is widely used as a tool for the management of all illnesses, aligning with the compliance of treatment regimens and impelling the oxygen therapy market growth.

Increasing prevalence of respiratory diseases

According to an article published on the website of the World Health Organization (WHO) in 2023, the third leading cause of death worldwide is COPD, causing 3.23 million deaths in 2019. Oxygen therapy is extremely necessary during the treatment of symptoms of quite common diseases such as COPD, asthma, interstitial lung disease, or pneumonia. This is because respiratory ailments are injurious, and only extended treatment can help those patients, who have such conditions. Furthermore, oxygen therapy is of great importance in the prescription of sufficient oxygen in the blood for chronic respiratory illnesses, thus impelling market growth.

Aging population

The elderly patients suffer frequent respiratory conditions including COPD, emphysema as well as pneumonia, and the only known cure is the use of oxygen therapy. Respiratory diseases in old people may also be accompanied by other diseases such as hypertension, heart disease, and diabetes, which worsen respiratory diseases and therefore make oxygen therapy mandatory. Features characteristic of elders are the immune system that draws several infections leading to major respiratory illnesses. The elders also suffer from severe respiratory illnesses due to low immune system strength. An article published on the website of the International Monetary Fund (IMF) eLibrary shows that by 2050 the global share of people aged 80 and older is expected to quadruple to almost 5%.

Emerging Developments Reshaping the Market Landscape

The market is witnessing steady growth, influenced by several concurrent developments. A primary factor is the rising incidence of chronic respiratory diseases, particularly COPD, sleep apnea, and pulmonary fibrosis. Highlighting the widespread nature of sleep apnea, an industry study in the United States revealed that 26% of adults aged 30 to 70 exhibited at least mild obstructive sleep apnea, while 10% were found to have moderate to severe forms of the condition. This continues to drive demand for long-term oxygen support. Alongside this, manufacturers are focusing on portable and wearable oxygen delivery systems. Compact oxygen concentrators and lightweight wearable units allow users to maintain mobility, making home and travel use more convenient. In addition to this, personalized oxygen therapy is gaining attention as clinicians and device manufacturers seek to tailor oxygen flow rates and delivery modes to individual needs. Simultaneously, an uptick in regulatory approvals, particularly for portable and smart oxygen delivery devices, reflects both safety advancements and growing market confidence. Also, strategic collaborations between device manufacturers, hospitals, and home healthcare providers have further supported product innovation and broader adoption across both clinical and non-clinical settings.

OXYGEN THERAPY INDUSTRY SEGMENTATION:

Analysis by Product:

• Oxygen Source Equipment
  • Oxygen Cylinders
  • Oxygen Concentrators
  • Liquid Oxygen Devices
  • PAP Devices
• Oxygen Delivery Devices
  • Oxygen Masks
  • Nasal Cannula
  • Venturi Masks
  • Non-rebreather Masks
  • Bag Valve Masks
  • CPAP Masks
  • Others

Oxygen source equipment stands as the largest component in 2025, holding around 57.6% of the market. It is essential for oxygen treatment because it supplies patients with the oxygen they require. Without these devices, it would be hard to provide oxygen to patients in need, making them market-essential. These devices are used in various contexts, including hospitals, clinics, and home healthcare facilities. Their adaptability and requirement in many healthcare settings are driving their strong adoption. Moreover, continuous advancements and improvements in oxygen source equipment, such as portable and lightweight designs, enhanced efficiency, and user-friendly features, are transforming the oxygen therapy market overview.

Analysis by Application:

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia

Chronic obstructive pulmonary disease (COPD) leads the market with around 32.9% of the market share in 2025. The high incidence of COPD directly corresponds to a large patient population requiring oxygen therapy, making it the most common application area. COPD is a progressive and chronic ailment that usually worsens with time, and strongly demands long-term care procedures and treatment. Patients with COPD may require continuous or intermittent oxygen therapy to control symptoms and maintain their quality of life. Oxygen treatment alleviates respiratory difficulties and severe shortness of breath, making it an essential part of COPD management, thereby positively influencing the oxygen therapy market insights.

Analysis by End Use:

• Home Healthcare
• Hospitals

Home healthcare holds the largest market with around 32% of the market share in 2025. Many patients prefer to be treated at home rather than in hospitals or clinics for treatment. Home healthcare allows patients to continue their routines and stay in familiar environments, which benefits their overall well-being and satisfaction with the services. Additionally, home healthcare is more cost-effective than inpatient treatment in general. It eliminates long hospitalizations, reduces health costs, and relieves the burden on hospitals. This cost-saving is attractive to patients and healthcare providers. In portable oxygen concentrators and other home-use oxygen delivery systems, medical technology has made oxygen therapy more manageable for patients at home. Many of these gadgets have become easier to use, faster, and lightweight enhancing their application in the homes.

Analysis by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2025, North America accounted for the largest market share of 37.9%. There is a high incidence of respiratory diseases in the region including COPD, asthma, and sleep apnea due to several factors including aging, smoking, and pollution. The availability of sophisticated technologies, easy access to these technologies, and robust reimbursement strategies all contribute to the growth of the market. In addition, the growth of home care and portable and easy-to-use oxygen therapy devices enhance the ability of patients to manage their diseases from their homes. Furthermore, important players in this area are interested in increasing the storage capacities of oxygen. For instance, in 2024 Chart Industries announced the grand opening of its jumbo cryogenic tank manufacturing facility in Theodore, Alabama.

KEY REGIONAL TAKEAWAYS:

UNITED STATES OXYGEN THERAPY MARKET ANALYSIS

The adoption of oxygen therapy is witnessing a notable rise, fueled by the increasing investments in healthcare systems. For instance, in 2024, US healthcare companies securing venture capital deals over USD 15 Million saw a surge in investments, benefiting oxygen therapy advancements. This growth enhances access to innovative treatments, improving patient care and outcomes. As healthcare expenditures continue to grow, there is a greater emphasis on improving patient care, particularly for those with respiratory disorders. Enhanced healthcare infrastructures and access to advanced treatments have led to a higher demand for therapies such as oxygen therapy. The growing awareness of respiratory diseases and their impact on quality of life further drives the demand for these treatments. As the need for specialized care expands, healthcare facilities are better equipped to administer oxygen therapy, making it more accessible to patients in need. The increase in research funding and technological advancements in oxygen delivery systems are also contributing to the rise in therapy adoption, offering more efficient and comfortable solutions for individuals with respiratory challenges.

EUROPE OXYGEN THERAPY MARKET ANALYSIS

Chronic diseases have been steadily rising, leading to an increasing need for oxygen therapy as a crucial part of patient management. The rising incidence of chronic conditions, such as COPD and heart diseases, requires long-term treatment, often involving oxygen support. The growing number of aging individuals, many of whom suffer from chronic ailments, has also played a significant role in the increased demand for oxygen therapy. For instance, in 2022, 2.9% of the EU population was aged 85 or older, with projections indicating this share will surpass 10% by 2050. This demographic shift highlights the increasing demand for oxygen therapy. Hospitals and medical care facilities are increasingly focusing on advanced therapies to support these patients. Moreover, the importance of oxygen therapy in improving their quality of life has been well recognized. New treatment protocols and greater access to home-based oxygen support devices contribute to the widespread adoption, further supporting oxygen therapy market growth. As healthcare institutions continue to prioritize the treatment of chronic conditions, the adoption of oxygen therapy has become a vital element in improving long-term patient outcomes, particularly for individuals with ongoing respiratory needs.

ASIA PACIFIC OXYGEN THERAPY MARKET ANALYSIS

Asthma cases are on the rise across the region, leading to a surge in the adoption of oxygen therapy. For instance, asthma affects over 35 million people in India, contributing significantly to the growing number of asthma patients. Oxygen therapy offers a promising solution to alleviate symptoms and improve the quality of life for asthma patients. As asthma becomes more prevalent, patients need proper and constant therapy because of the rising frequency of the disease. This has led to an increased need for oxygen therapy which is fundamental in managing asthma by reducing the extent or destructiveness of the symptoms. Furthermore, treatments like oxygen therapy, and increased revenues are tied to the fact that the healthcare system in the region pays more attention to respiratory disorders as its foundation is being built up. As a result of development and innovations in the field of health, delivery systems for oxygen have improved and there is therefore increased capacity of the patient to be well cared for in both the hospital and at home. Enhancing the patient base, advanced treatment solutions, and enhancing consciousness levels regarding asthma management are major factors augmenting the oxygen therapy market share across the region.

LATIN AMERICA OXYGEN THERAPY MARKET ANALYSIS

With rising disposable income, more individuals in Latin America are seeking home healthcare solutions, including oxygen therapy. For instance, between 2021 and 2040, Latin America's total disposable income is projected to rise by nearly 60%, driven by regional disparities narrowing and technological advancements. This growth boosts demand for home healthcare services by enhancing affordability and accessibility. This economic growth is enabling a broader section of the population to afford at-home treatments for chronic respiratory conditions. The ability to manage health from the comfort of home is becoming more appealing, especially as the quality of healthcare services improves. Patients with respiratory illnesses prefer using client-transportable oxygen concentration equipment, which can be relocated in the home setting. Common hospital-based treatments are much more convenient and economical. The increased affordability of oxygen therapy as a home healthcare product along with easier access to healthcare products has played a vital part in the advancement of the therapy in the region. Rising disposable income is therefore central to the home health care oxygen therapy industry, thus driving the market forward.

MIDDLE EAST AND AFRICA OXYGEN THERAPY MARKET ANALYSIS

Healthcare facilities in the region have expanded significantly, improving access to critical care and oxygen therapy services. According to the Dubai Healthcare City Authority report, by 2022, Dubai saw a significant expansion in healthcare facilities, with 4,482 private medical establishments, including 56 hospitals, and 55,208 licensed professionals. The Dubai Health Authority forecasts a 10-15% growth in medical professionals and a 3-6% rise in facilities through 2023 and beyond. The increased availability of medical centers and specialized healthcare providers has facilitated easier access to therapies for individuals with respiratory needs. With an emphasis on upgrading healthcare infrastructure, there has been a significant push to enhance treatment options, including oxygen therapy, for patients with respiratory disorders. The expansion of healthcare facilities ensures that more people can access essential services, such as oxygen therapy, which is vital for those suffering from chronic respiratory conditions. This development is creating a more favorable environment for the growth of oxygen therapy adoption across the region.

COMPETITIVE LANDSCAPE:

The global oxygen therapy market is highly saturated, and companies are striving to maintain their position through innovation of products, strategic partnerships, and new product launches. One of the major trends is the creation of portable and wearable oxygen delivery devices for meeting the growing home healthcare equipment market. Additionally, to enhance the efficiency, flexibility, and portability of a device, companies are increasingly underlining the significance of research and development (R&D). Other factors that are influencing the market include the approval of regulations for advanced technology and developing collaborations with the healthcare sector. Also, through acquisitions and mergers, competition is being pressed through market consolidation and improvements in product offerings. They point to the emergence of new respiratory ailments on the market and the shift towards home-based solutions.

The report provides a comprehensive analysis of the competitive landscape in the oxygen therapy market with detailed profiles of all major companies, including:

• Allied Healthcare Products Inc.
• Becton Dickinson and Company
• DeVilbiss Healthcare LLC (Drive Medical Inc.)
• Fisher & Paykel Healthcare Limited
• General Electric Company
• Getinge AB
• Hersill SL
• Invacare Corporation
• Koninklijke Philips N.V
• Smiths Group plc
• Tecno-Gaz S.p.A.
• Teleflex Incorporated

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the oxygen therapy market?

2. What is the future outlook of the oxygen therapy market?

3. What are the key factors driving the oxygen therapy market?

4. Which region accounts for the largest oxygen therapy market share?

5. Which are the leading companies in the global oxygen therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Oxygen Therapy Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Oxygen Source Equipment
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Oxygen Cylinders
    • 6.1.2.2 Oxygen Concentrators
    • 6.1.2.3 Liquid Oxygen Devices
    • 6.1.2.4 PAP Devices
  • 6.1.3 Market Forecast
• 6.2 Oxygen Delivery Devices
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Oxygen Masks
    • 6.2.2.2 Nasal Cannula
    • 6.2.2.3 Venturi Masks
    • 6.2.2.4 Non-rebreather Masks
    • 6.2.2.5 Bag Valve Masks
    • 6.2.2.6 CPAP Masks
    • 6.2.2.7 Others
  • 6.2.3 Market Forecast

7 Market Breakup by Application

• 7.1 Chronic Obstructive Pulmonary Disease
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Asthma
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Obstructive Sleep Apnea
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Respiratory Distress Syndrome
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Cystic Fibrosis
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Pneumonia
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Others
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by End Use

• 8.1 Home Healthcare
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hospitals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Allied Healthcare Products Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Fisher & Paykel Healthcare Limited
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
  • 14.3.5 General Electric Company
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Getinge AB
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Hersill SL
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Invacare Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Koninklijke Philips N.V
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Smiths Group plc
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Tecno-Gaz S.p.A.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Teleflex Incorporated
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis